Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
97.900,00
-0,21%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Twist Bioscience Corporation (TWST) Twist Bioscience Corporation (TWST) Notizie

TWST

Twist Bioscience (TWST)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TWST
DataOraFonteTitoloSimboloCompagnia
03/01/202521:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
26/12/202422:52Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TWSTTwist Bioscience Corporation
26/12/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
19/12/202414:00Business WireTwist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TWSTTwist Bioscience Corporation
18/11/202422:26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TWSTTwist Bioscience Corporation
18/11/202422:10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TWSTTwist Bioscience Corporation
18/11/202413:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TWSTTwist Bioscience Corporation
18/11/202413:15Business WireTwist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial ResultsNASDAQ:TWSTTwist Bioscience Corporation
15/11/202422:05Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TWSTTwist Bioscience Corporation
14/11/202414:00Business WireTwist Bioscience to Present at 7th Annual Evercore HealthCONx ConferenceNASDAQ:TWSTTwist Bioscience Corporation
07/11/202422:05Business WireTwist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:TWSTTwist Bioscience Corporation
31/10/202413:00GlobeNewswire Inc.Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AINASDAQ:TWSTTwist Bioscience Corporation
30/10/202413:00Business WireTwist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population GenomicsNASDAQ:TWSTTwist Bioscience Corporation
24/10/202414:00Business WireTwist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024NASDAQ:TWSTTwist Bioscience Corporation
22/10/202414:00Business WireTwist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in CashNASDAQ:TWSTTwist Bioscience Corporation
15/10/202414:00Business WireTwist Bioscience Appoints Mike Fero, Ph.D., as Chief Information OfficerNASDAQ:TWSTTwist Bioscience Corporation
12/09/202414:00Business WireTwist Bioscience Achieves LEED Certification for Sustainable Operations and MaintenanceNASDAQ:TWSTTwist Bioscience Corporation
09/09/202414:00Business WireTwist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment PanelsNASDAQ:TWSTTwist Bioscience Corporation
27/08/202414:00Business WireTwist Bioscience to Present at Baird Global Healthcare Conference 2024NASDAQ:TWSTTwist Bioscience Corporation
08/08/202414:00Business WireTwist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kbNASDAQ:TWSTTwist Bioscience Corporation
05/08/202414:00Business WireTwist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for BiocatalysisNASDAQ:TWSTTwist Bioscience Corporation
02/08/202422:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TWSTTwist Bioscience Corporation
02/08/202413:30Business WireTwist Bioscience Reports Fiscal Third Quarter 2024 Financial ResultsNASDAQ:TWSTTwist Bioscience Corporation
18/07/202414:00Business WireTwist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody LibrariesNASDAQ:TWSTTwist Bioscience Corporation
11/07/202414:00Business WireTwist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024NASDAQ:TWSTTwist Bioscience Corporation
10/07/202414:00Business WireTwist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express AntibodiesNASDAQ:TWSTTwist Bioscience Corporation
09/07/202414:00Business WireTwist Bioscience Launches Synthetic RNA Control for H5N1 Influenza ANASDAQ:TWSTTwist Bioscience Corporation
06/06/202414:00Business WireTwist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint InhibitorNASDAQ:TWSTTwist Bioscience Corporation
04/06/202414:00Business WireTwist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI SafetyNASDAQ:TWSTTwist Bioscience Corporation
23/05/202414:00Business WireTwist Bioscience to Present at Upcoming Investor ConferencesNASDAQ:TWSTTwist Bioscience Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TWST

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
ENEL
Enel
BIT
SPM
Saipem
BIT
CPR
Davide Campari
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
TIT
Telecom Italia
BIT
IVG
Iveco Group NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network